Lattulosio Eg (Lactulose)

Lactulose is a synthetic sugar that reaches the colon unchanged, where intestinal bacteria ferment it into short‑chain fatty acids. This process raises the osmotic pressure in the lumen, drawing water into the bowel and softening stool. The acidic environment also converts ammonia to ammonium, which is less readily absorbed, thereby lowering systemic ammonia levels.

The appropriate dose of lactulose is individualized by a healthcare professional based on the patient’s condition, age, renal function, and response to therapy. Prescribers typically start with a low dose and adjust gradually to achieve the desired clinical effect while minimizing side effects.

Safety data for lactulose during pregnancy and lactation are limited. It is generally considered low risk because it is minimally absorbed, but the decision to use it should be made by a qualified clinician after weighing potential benefits against any uncertain risks.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Lattulosio Eg. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lactulose is an osmotic laxative, differing from stimulant laxatives such as bisacodyl, which act by directly stimulating intestinal motility. Osmotic agents like lactulose draw water into the colon, offering a gentler, often better‑tolerated option for chronic constipation and providing the added benefit of ammonia reduction in liver disease.

Store Lattulosio Eg at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Lattulosio Eg is taken orally, usually as a liquid solution. It can be measured with a calibrated dosing device and swallowed directly or mixed with a small amount of water or juice to improve palatability, following the prescribing clinician’s instructions.

Serious risks include severe electrolyte disturbances such as hyponatremia or hypokalemia, marked dehydration from excessive diarrhea, and rare allergic reactions. Patients should be monitored for signs of these conditions, especially when high doses are used or when concomitant medications affect fluid and electrolyte balance.

Lactulose should be avoided in individuals with known hypersensitivity to the drug, those with intestinal obstruction, perforation, or severe inflammatory bowel disease, and patients with uncontrolled diabetes without appropriate monitoring, as it may affect carbohydrate metabolism.